XT
IMNM icon

XTX Topco’s Immunome IMNM Stock Holding History

XTX Topco’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.68M Buy
126,648
+66,150
+109% +$1.42M 0.03% 833
2026
Q1 		$1.32M Buy
60,498
+42,696
+240% +$950K 0.02% 1182
2025
Q4 		$382K Sell
17,802
-52,712
-75% -$925K 0.01% 1851
2025
Q3 		$826K Buy
+70,514
New +$701K 0.04% 700
2024
Q4 		– Sell
-24,823
Closed -$363K – 2580
2024
Q3 		$363K Buy
+24,823
New +$353K 0.03% 1062

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

XTX Topco's IMNM Position: Q2 2026 in Review

XTX Topco increased its Immunome (IMNM) stake by 109% in Q2 2026, buying an estimated $1.42M and bringing the position to 126,648 shares worth $2.68M. The position accounts for 0.03% of the portfolio, ranked #833.

XTX Topco first reported a position in IMNM in Q3 2024 and has held it in 5 quarters since. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • XTX Topco held 126,648 shares of Immunome worth $2.68M as of Q2 2026.
  • XTX Topco bought 66,150 Immunome shares in Q2 2026, an estimated $1.42M.
  • Immunome made up 0.03% of XTX Topco's portfolio in Q2 2026, its #833 holding.
  • XTX Topco first reported a position in Immunome in Q3 2024 and has held it in 5 quarters since.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.